Steven Lim

Array ( [id] => 5403997 [patent_doc_number] => 20090239311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Method of Differentially Diagnosing Dementias' [patent_app_type] => utility [patent_app_number] => 12/466676 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19841 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239311.pdf [firstpage_image] =>[orig_patent_app_number] => 12466676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5551817 [patent_doc_number] => 20090285803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'ANTI-PirB ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/465169 [patent_app_country] => US [patent_app_date] => 2009-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 19575 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285803.pdf [firstpage_image] =>[orig_patent_app_number] => 12465169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273538 [patent_doc_number] => 08637470 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Small humanin-like peptides' [patent_app_type] => utility [patent_app_number] => 12/989688 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 21585 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12989688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8409957 [patent_doc_number] => 08273352 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Humanized anti-factor D antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/430479 [patent_app_country] => US [patent_app_date] => 2009-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 41968 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12430479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558209 [patent_doc_number] => 20090269786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'RHO1-Gamma Amino Butyric Acid C Receptor-Specific Antibodies' [patent_app_type] => utility [patent_app_number] => 12/430716 [patent_app_country] => US [patent_app_date] => 2009-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13546 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20090269786.pdf [firstpage_image] =>[orig_patent_app_number] => 12430716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5984784 [patent_doc_number] => 20110097392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'ANTIBODY BOUND SYNTHETIC VESICLE CONTAINING MOLECULES FOR DELIVER TO CENTRAL AND PERIPHERAL NERVOUS SYSTEM CELLS' [patent_app_type] => utility [patent_app_number] => 12/988479 [patent_app_country] => US [patent_app_date] => 2009-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10719 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097392.pdf [firstpage_image] =>[orig_patent_app_number] => 12988479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479670 [patent_doc_number] => 20090202627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'METHODS AND COMPOSITIONS FOR DISEASES ASSOCIATED WITH AMYLOIDOSIS' [patent_app_type] => utility [patent_app_number] => 12/424034 [patent_app_country] => US [patent_app_date] => 2009-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10573 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202627.pdf [firstpage_image] =>[orig_patent_app_number] => 12424034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6377625 [patent_doc_number] => 20100081613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'METHODS AND COMPOSITIONS FOR ENHANCING MEMORY' [patent_app_type] => utility [patent_app_number] => 12/414160 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 23967 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081613.pdf [firstpage_image] =>[orig_patent_app_number] => 12414160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9777670 [patent_doc_number] => 08852874 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitro' [patent_app_type] => utility [patent_app_number] => 12/392267 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10557 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12392267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14729017 [patent_doc_number] => 10383887 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-20 [patent_title] => Preventing and treating amyloid-beta deposition by stimulation of innate immunity [patent_app_type] => utility [patent_app_number] => 12/918739 [patent_app_country] => US [patent_app_date] => 2009-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12277 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12918739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101682 [patent_doc_number] => 20110165174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'Alternatively Transcribed Genes Associated with Memory Consolidation' [patent_app_type] => utility [patent_app_number] => 12/867378 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 36861 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165174.pdf [firstpage_image] =>[orig_patent_app_number] => 12867378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480750 [patent_doc_number] => 20090203707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'METHODS FOR TREATING PAIN' [patent_app_type] => utility [patent_app_number] => 12/367403 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18543 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203707.pdf [firstpage_image] =>[orig_patent_app_number] => 12367403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10627614 [patent_doc_number] => 09345753 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Vaccine for alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 12/812712 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16113 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12812712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846261 [patent_doc_number] => 08455442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Peptides having binding affinity to an antibody which recognizes an epitope on an α1 loop 2 or β2 loop 1 of an adrenoreceptor' [patent_app_type] => utility [patent_app_number] => 12/735416 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 7 [patent_no_of_words] => 6756 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12735416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4511818 [patent_doc_number] => 07910106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-22 [patent_title] => 'Combinations of SAP depleting agents and anti-SAP antibodies' [patent_app_type] => utility [patent_app_number] => 12/346023 [patent_app_country] => US [patent_app_date] => 2008-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 34 [patent_no_of_words] => 28399 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/910/07910106.pdf [firstpage_image] =>[orig_patent_app_number] => 12346023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10844040 [patent_doc_number] => 08871212 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-28 [patent_title] => 'Amyloid-beta polypeptide vaccine' [patent_app_type] => utility [patent_app_number] => 12/339841 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28060 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12339841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070136 [patent_doc_number] => 20110044986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'ANTI-AMYLOID ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/809563 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 31904 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044986.pdf [firstpage_image] =>[orig_patent_app_number] => 12809563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10898308 [patent_doc_number] => 08921523 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Humanized anti-beta-amyloid antibodies' [patent_app_type] => utility [patent_app_number] => 12/330541 [patent_app_country] => US [patent_app_date] => 2008-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 33754 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12330541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992529 [patent_doc_number] => 20110014182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'ANTIGEN BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/746837 [patent_app_country] => US [patent_app_date] => 2008-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 33662 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014182.pdf [firstpage_image] =>[orig_patent_app_number] => 12746837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485284 [patent_doc_number] => 20090275049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'EphA4 POLYPEPTIDE HAVING A NOVEL ACTIVITY AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/325418 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 33181 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275049.pdf [firstpage_image] =>[orig_patent_app_number] => 12325418 [rel_patent_id] =>[rel_patent_doc_number] =>)